Both GLP-1 and GIP can stimulate pancreatic beta cells to secrete insulin in a glucose-dependent manner to control blood glucose levels with hypoglycemia occurring very rarely as an adverse effect (65). This evidence concerns the gene INS and Hypoglycemia.